beacon hospital logo

物种稀有,寿命低。多发性骨髓瘤是一种可怕的血癌

Home / 物种稀有,寿命低。多发性骨髓瘤是一种可怕的血癌
09/10/2023
[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_spacing=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_shadow=”none” column_border_radius=”none” column_link_target=”_self” column_position=”default” gradient_direction=”left_to_right” overlay_strength=”0.3″ width=”1/1″ tablet_width_inherit=”default” tablet_text_alignment=”default” phone_text_alignment=”default” animation_type=”default” bg_image_animation=”none” border_type=”simple” column_border_width=”none” column_border_style=”solid”][image_with_animation image_url=”17860″ image_size=”full” animation_type=”entrance” animation=”Fade In” hover_animation=”none” alignment=”” border_radius=”none” box_shadow=”none” image_loading=”default” max_width=”100%” max_width_mobile=”default”][vc_column_text]多发性骨髓瘤是一种罕见的血癌,其危险因素可能随着年龄的增长而增加。根据美国癌症协会的数据,每 132 人中就有 1 人(即 0.78%)有患此类癌症的风险。

美国国家癌症研究所宣布,估计有 35,000 例多发性骨髓瘤新病例,估计死亡率为 170,405 例。

多发性骨髓瘤有治愈方法吗?这种癌症患者的生活质量如何?

多发性骨髓瘤是一种浆细胞癌症,浆细胞由淋巴细胞或白细胞组成,对我们的免疫系统至关重要。浆细胞通过产生抵抗入侵和炎症的抗体来应对感染。

当浆细胞不受控制地繁殖,导致骨髓中白细胞过度产生时,就会发生骨髓瘤癌症。[/vc_column_text][/vc_column][/vc_row][vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_spacing=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_shadow=”none” column_border_radius=”none” column_link_target=”_self” column_position=”default” gradient_direction=”left_to_right” overlay_strength=”0.3″ width=”1/1″ tablet_width_inherit=”default” tablet_text_alignment=”default” phone_text_alignment=”default” animation_type=”default” bg_image_animation=”none” border_type=”simple” column_border_width=”none” column_border_style=”solid”][vc_custom_heading text=”骨髓移植” use_theme_fonts=”yes”][vc_column_text]宝康医院的内科兼临床血液学专家医生 Dr Tengku Ahmad Hidayat 解释了多发性骨髓瘤的治疗:“化疗很少用于治疗多发性骨髓瘤,除非它是一种侵袭性癌细胞。靶向治疗和免疫 多发性骨髓瘤可采用多种治疗方法进行治疗。

靶向治疗用于控制细胞生长,免疫疗法帮助免疫系统攻击癌细胞。在某些情况下,化疗可以与靶向治疗相结合,以有效杀死癌症。

另一种选择是骨髓移植,尽管该手术的资格取决于患者的年龄(65 岁或以下)和健康状况(无慢性疾病)。”[/vc_column_text][/vc_column][/vc_row][vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_spacing=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_shadow=”none” column_border_radius=”none” column_link_target=”_self” column_position=”default” gradient_direction=”left_to_right” overlay_strength=”0.3″ width=”1/1″ tablet_width_inherit=”default” tablet_text_alignment=”default” phone_text_alignment=”default” animation_type=”default” bg_image_animation=”none” border_type=”simple” column_border_width=”none” column_border_style=”solid”][vc_custom_heading text=”生存的机会” use_theme_fonts=”yes”][vc_column_text]“如果早期发现,多发性骨髓瘤的治愈率很高:在第一阶段,生存率可达 10 年。在第三阶段,生存期为两年或更短,”Dr Tengku 补充道。

根据修订后的多发性骨髓瘤国际分期系统,5年生存率为40%至82%。 Dr Tengku 表示,“多发性骨髓瘤是可以治疗的,尽管存在复发的风险。”

Dr Tengku 说,” 多发性骨髓瘤患者应该吃健康、均衡的饮食来获取能量,避免生食,以避免因免疫系统减弱而导致感染的风险。除此之外,患者可以进行日常活动,骨折或肾脏问题的患者除外。[/vc_column_text][/vc_column][/vc_row][vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_spacing=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_shadow=”none” column_border_radius=”none” column_link_target=”_self” column_position=”default” gradient_direction=”left_to_right” overlay_strength=”0.3″ width=”1/1″ tablet_width_inherit=”default” tablet_text_alignment=”default” phone_text_alignment=”default” animation_type=”default” bg_image_animation=”none” border_type=”simple” column_border_width=”none” column_border_style=”solid”][vc_column_text]他总结道:“多发性骨髓瘤无法预防,早期发现、早期治疗可以提供最佳预后。”[/vc_column_text][vc_row_inner column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” text_align=”left” row_position=”default” row_position_tablet=”inherit” row_position_phone=”inherit” overflow=”visible” pointer_events=”all”][vc_column_inner column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_spacing=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_shadow=”none” column_border_radius=”none” column_link_target=”_self” gradient_direction=”left_to_right” overlay_strength=”0.3″ width=”1/2″ tablet_width_inherit=”default” animation_type=”default” bg_image_animation=”none” border_type=”simple” column_border_width=”none” column_border_style=”solid”][image_with_animation image_url=”17627″ image_size=”full” animation_type=”entrance” animation=”Fade In” hover_animation=”none” alignment=”” border_radius=”none” box_shadow=”none” image_loading=”default” max_width=”100%” max_width_mobile=”default”][/vc_column_inner][vc_column_inner column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_spacing=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_shadow=”none” column_border_radius=”none” column_link_target=”_self” gradient_direction=”left_to_right” overlay_strength=”0.3″ width=”1/2″ tablet_width_inherit=”default” animation_type=”default” bg_image_animation=”none” border_type=”simple” column_border_width=”none” column_border_style=”solid”][image_with_animation image_url=”17628″ image_size=”full” animation_type=”entrance” animation=”Fade In” hover_animation=”none” alignment=”” border_radius=”none” box_shadow=”none” image_loading=”default” max_width=”100%” max_width_mobile=”default”][/vc_column_inner][/vc_row_inner][vc_column_text]阅读完整文章:Sinar Harian[/vc_column_text][/vc_column][/vc_row][vc_row type=”full_width_background” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” bg_image=”32″ bg_position=”left top” background_image_loading=”default” bg_repeat=”no-repeat” scene_position=”center” top_padding=”2%” bottom_padding=”2%” text_color=”dark” text_align=”center” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” advanced_gradient_angle=”0″ overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none” gradient_type=”default” shape_type=””][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_spacing=”default” centered_text=”true” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_shadow=”none” column_border_radius=”none” column_link_target=”_self” column_position=”default” advanced_gradient_angle=”0″ gradient_direction=”left_to_right” overlay_strength=”0.3″ width=”1/1″ tablet_width_inherit=”default” tablet_text_alignment=”default” phone_text_alignment=”default” animation_type=”default” bg_image_animation=”none” border_type=”simple” column_border_width=”none” column_border_style=”solid” gradient_type=”default”][vc_column_text]推荐医生:[/vc_column_text][vc_column_text]

Dr-Tengku-Ahmad-Hidayat-Bin-Tengku-K-Aziz-Bone-Marrow-Transplant-Beacon-Hospital-Malaysia

Dr Tengku Ahmad Hidayat Bin Tengku K Aziz

内科和临床血液专科医生

[/vc_column_text][nectar_btn size=”large” button_style=”regular” button_color_2=”Accent-Color” icon_family=”none” text=”立即预约” url=”https://www.staging2.beaconhospital.com.my/zh/consultant/dr-tengku-ahmad-hidayat-bin-tengku-k-aziz/”][/vc_column][/vc_row]

Featured Doctor:

Dr Tengku Ahmad Hidayat

临床血液与内科专科医生
View Doctor
Share This Article!
Latest Highlights
Latest Articles
信息
参观时间:
10:00 – 22:00
总机:
+603 7620 7979 +603 7787 2992
咨询预约电话:
+603 7118 7878 +6012 328 6913
电子邮件:
[email protected]
招聘咨询 / 人力资源:
[email protected]
Beacon Hospital Sdn. Bhd.
200301019556 (621976-D)
1, Jalan 215, Seksyen 51,
Off Jalan Templer,
46050 Petaling Jaya, Selangor.
订阅我们的新闻通讯
随时了解寶康医院最新的医疗趋势、专家建议和最新活动。
订阅我们的新闻通讯
随时了解寶康医院最新的医疗趋势、专家建议和最新活动。
© 2026 Beacon Hospital (寶康医院). SDN. BHD. 200301019556 (621976-D) | (KKLIU 0573/2028)

Subscribe for Exclusive Medical & Health Insight - Straight to Your Inbox

Stay up-to-date with the latest healthcare trends, expert advice and latest events at Beacon Hospital. Our newsletter brings you health tips and news to keep you informed and inspired - let's subscribe now!